See more : Meta Platforms, Inc. (FB2A.F) Income Statement Analysis – Financial Results
Complete financial analysis of Apeloa Pharmaceutical Co.,Ltd (000739.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apeloa Pharmaceutical Co.,Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- I2PO Société anonyme (I2PO.PA) Income Statement Analysis – Financial Results
- Global Fashion Group S.A. (GFG.DE) Income Statement Analysis – Financial Results
- Close Brothers Group plc (CBG.L) Income Statement Analysis – Financial Results
- Mono Next Public Company Limited (MONO.BK) Income Statement Analysis – Financial Results
- Envipco Holding N.V. (ENVIP.OL) Income Statement Analysis – Financial Results
Apeloa Pharmaceutical Co.,Ltd (000739.SZ)
About Apeloa Pharmaceutical Co.,Ltd
Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. It also provides contract research and development, and production services for pharmaceutical companies. The company is headquartered in Dongyang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.47B | 10.54B | 8.94B | 7.88B | 7.21B | 6.38B | 5.55B | 4.77B | 4.34B | 4.23B | 3.90B | 3.48B | 1.53B | 1.52B | 1.37B | 1.25B | 1.04B | 1.15B | 1.04B | 830.52M | 770.25M | 659.33M | 141.84M | 178.82M | 225.65M | 418.09M | 367.70M | 368.68M | 344.32M | 331.16M |
| Cost of Revenue | 8.62B | 8.02B | 6.57B | 5.68B | 4.88B | 4.34B | 3.84B | 3.44B | 3.15B | 3.13B | 3.02B | 2.67B | 1.24B | 1.20B | 1.07B | 1.01B | 845.83M | 915.43M | 833.39M | 671.38M | 611.25M | 511.02M | 130.74M | 156.57M | 187.10M | 366.31M | 313.12M | 313.64M | 294.64M | 288.03M |
| Gross Profit | 2.85B | 2.52B | 2.37B | 2.20B | 2.33B | 2.04B | 1.71B | 1.33B | 1.19B | 1.10B | 882.77M | 807.36M | 297.58M | 319.86M | 298.93M | 238.93M | 195.69M | 233.13M | 202.03M | 159.14M | 159.00M | 148.32M | 11.09M | 22.25M | 38.54M | 51.78M | 54.58M | 55.04M | 49.68M | 43.13M |
| Gross Profit Ratio | 24.86% | 23.90% | 26.54% | 27.96% | 32.37% | 31.93% | 30.84% | 27.83% | 27.39% | 26.02% | 22.64% | 23.20% | 19.39% | 21.03% | 21.85% | 19.11% | 18.79% | 20.30% | 19.51% | 19.16% | 20.64% | 22.50% | 7.82% | 12.44% | 17.08% | 12.39% | 14.84% | 14.93% | 14.43% | 13.02% |
| Research & Development | 624.87M | 532.92M | 446.22M | 350.06M | 359.89M | 269.65M | 259.18M | 210.14M | 183.24M | 129.98M | 98.50M | 97.82M | 49.88M | 47.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.57M | 74.70M | 123.91M | 110.66M | 143.49M | 162.37M | 159.41M | 113.00M | 132.90M | 104.33M | 77.93M | 74.65M | 34.25M | 32.31M | 152.65M | 124.51M | 97.68M | 95.38M | 73.75M | 55.01M | 57.26M | 48.71M | 19.02M | 20.45M | 22.80M | 17.86M | 12.65M | 16.78M | 15.87M | 14.53M |
| Selling & Marketing | 509.68M | 535.26M | 452.53M | 573.62M | 835.34M | 808.93M | 515.01M | 316.84M | 242.66M | 222.73M | 182.55M | 167.60M | 71.33M | 70.46M | 58.47M | 44.34M | 30.07M | 38.68M | 48.96M | 33.68M | 31.86M | 28.26M | 12.88M | 14.90M | 15.80M | 15.88M | 15.45M | 17.26M | 16.24M | 16.12M |
| SG&A | 1.07B | 609.96M | 576.43M | 684.28M | 978.83M | 971.30M | 674.43M | 429.84M | 375.56M | 327.06M | 260.48M | 242.25M | 105.58M | 102.77M | 211.12M | 168.86M | 127.75M | 134.07M | 122.71M | 88.69M | 89.12M | 76.97M | 31.90M | 35.36M | 38.60M | 33.74M | 28.09M | 34.04M | 32.11M | 30.65M |
| Other Expenses | -42.00M | 313.22M | 264.69M | 216.90M | 269.63M | -30.83M | 3.93M | 74.42M | 66.76M | 28.74M | 22.68M | 27.09M | 16.14M | 7.22M | 3.89M | 1.22M | 6.57M | 2.52M | 1.66M | 1.54M | 709.50K | 2.43M | 7.45M | 16.68M | 13.89M | 19.77M | 7.09M | 5.76M | 6.40M | 4.13M |
| Operating Expenses | 1.63B | 1.46B | 1.29B | 1.25B | 1.61B | 1.52B | 1.26B | 1.02B | 913.38M | 744.94M | 634.87M | 550.14M | 252.66M | 250.39M | 217.99M | 173.53M | 132.64M | 139.13M | 125.21M | 90.19M | 90.55M | 78.46M | 32.67M | 35.96M | 39.81M | 35.41M | 29.38M | 35.77M | 33.49M | 31.33M |
| Cost & Expenses | 10.25B | 9.48B | 7.86B | 6.93B | 6.48B | 5.86B | 5.10B | 4.46B | 4.06B | 3.88B | 3.65B | 3.22B | 1.49B | 1.45B | 1.29B | 1.19B | 978.47M | 1.05B | 958.59M | 761.57M | 701.80M | 589.48M | 163.41M | 192.53M | 226.91M | 401.72M | 342.50M | 349.41M | 328.13M | 319.36M |
| Interest Income | 113.47M | 75.83M | 75.35M | 24.88M | 7.29M | 5.36M | 4.17M | 8.91M | 12.23M | 19.34M | 17.17M | 11.16M | 3.61M | 2.90M | 4.80M | 6.78M | 3.18M | 4.04M | 1.28M | 1.04M | 1.93M | 1.88M | 125.34K | 907.88K | -0.44 | -0.86 | -0.55 | -0.09 | -0.56 | -0.77 |
| Interest Expense | 34.23M | 59.23M | 35.72M | 16.01M | 30.15M | 42.01M | 62.05M | 62.33M | 66.05M | 80.20M | 82.07M | 107.57M | 40.36M | 37.67M | 36.18M | 34.83M | 37.55M | 33.69M | 23.73M | 17.83M | 13.48M | 16.42M | 8.59M | 6.26M | 2.83M | 1.57M | 849.99K | 5.08M | 4.38M | 2.01M |
| Depreciation & Amortization | 558.97M | 394.61M | 362.56M | 348.54M | 356.86M | 330.50M | 332.74M | 302.56M | 286.24M | 247.77M | 227.52M | 193.33M | 100.49M | 90.10M | 82.28M | 66.37M | 52.41M | 53.08M | 44.39M | 37.66M | 33.53M | 27.30M | 4.12M | 6.13M | 6.07M | 4.48M | -5.91M | -687.47K | -2.15M | -2.30M |
| EBITDA | 1.81B | 1.47B | 1.50B | 1.28B | 1.02B | 819.67M | 671.25M | 639.97M | 546.23M | 637.70M | 445.50M | 388.10M | 328.38M | 130.37M | 156.23M | 128.64M | 121.22M | 152.22M | 119.64M | 104.20M | 97.09M | 94.86M | -12.82M | 7.51M | 4.80M | 17.64M | 25.20M | 19.27M | 16.19M | 11.80M |
| EBITDA Ratio | 15.75% | 14.79% | 17.66% | 16.61% | 14.59% | 13.66% | 13.68% | 15.82% | 14.98% | 17.39% | 13.88% | 14.16% | 10.55% | 11.00% | 12.43% | 10.89% | 11.80% | 12.86% | 11.55% | 12.55% | 12.60% | 14.39% | -9.04% | 6.84% | 2.10% | 4.99% | 6.85% | 5.23% | 4.70% | 3.56% |
| Operating Income | 1.22B | 1.01B | 1.12B | 969.71M | 644.15M | 490.54M | 335.69M | 273.64M | 202.34M | 343.07M | 185.48M | 143.55M | -11.39M | 21.17M | 34.57M | 26.67M | 25.36M | 61.36M | 52.92M | 48.65M | 50.72M | 49.89M | -25.05M | 4.89M | 8.89M | 30.60M | 31.11M | 19.96M | 18.34M | 14.10M |
| Operating Income Ratio | 10.63% | 9.59% | 12.52% | 12.31% | 8.93% | 7.69% | 6.05% | 5.73% | 4.66% | 8.11% | 4.76% | 4.12% | -0.74% | 1.39% | 2.53% | 2.13% | 2.43% | 5.34% | 5.11% | 5.86% | 6.58% | 7.57% | -17.66% | 2.73% | 3.94% | 7.32% | 8.46% | 5.41% | 5.33% | 4.26% |
| Total Other Income/Expenses | -15.50M | 442.62K | -5.28M | -8.55M | -10.43M | -44.35M | 3.93M | 35.39M | 44.66M | 34.14M | 20.26M | -67.76M | 19.89M | -41.98M | -29.51M | -37.97M | -31.79M | -29.05M | -28.37M | -21.72M | -641.40K | 1.26M | -491.05K | -8.87M | 978.59K | 3.97M | 2.43M | -6.48K | -116.88K | -169.29K |
| Income Before Tax | 1.20B | 1.01B | 1.11B | 961.15M | 633.73M | 462.20M | 339.62M | 335.33M | 247.01M | 377.21M | 205.74M | 168.28M | 3.85M | 27.35M | 37.77M | 27.43M | 31.26M | 60.97M | 51.52M | 48.71M | 50.08M | 51.15M | -25.54M | 6.02M | 9.86M | 34.57M | 33.54M | 19.96M | 18.22M | 13.93M |
| Income Before Tax Ratio | 10.50% | 9.60% | 12.46% | 12.20% | 8.79% | 7.25% | 6.12% | 7.03% | 5.69% | 8.91% | 5.28% | 4.84% | 0.25% | 1.80% | 2.76% | 2.19% | 3.00% | 5.31% | 4.98% | 5.86% | 6.50% | 7.76% | -18.01% | 3.37% | 4.37% | 8.27% | 9.12% | 5.41% | 5.29% | 4.21% |
| Income Tax Expense | 149.34M | 22.89M | 158.53M | 144.42M | 80.33M | 91.63M | 83.03M | 72.43M | 38.78M | 50.49M | 44.76M | 33.73M | 614.75K | 7.33M | 4.91M | 1.43M | 3.44M | 9.83M | 5.42M | 11.19M | 13.39M | 17.16M | 505.10K | -1.49M | 2.00M | 8.52M | 10.54M | 5.73M | 5.23M | 3.37M |
| Net Income | 1.06B | 989.17M | 955.55M | 816.73M | 553.40M | 370.57M | 256.59M | 262.90M | 208.23M | 322.16M | 167.36M | 137.13M | 8.25M | 23.79M | 34.09M | 29.06M | 30.44M | 51.96M | 43.75M | 35.63M | 34.19M | 31.59M | -25.87M | 7.48M | 7.63M | 25.73M | 23.00M | 14.22M | 12.99M | 10.56M |
| Net Income Ratio | 9.20% | 9.38% | 10.69% | 10.37% | 7.67% | 5.81% | 4.62% | 5.51% | 4.80% | 7.61% | 4.29% | 3.94% | 0.54% | 1.56% | 2.49% | 2.32% | 2.92% | 4.52% | 4.23% | 4.29% | 4.44% | 4.79% | -18.24% | 4.18% | 3.38% | 6.15% | 6.26% | 3.86% | 3.77% | 3.19% |
| EPS | 0.90 | 0.85 | 0.81 | 0.69 | 0.47 | 0.31 | 0.22 | 0.23 | 0.18 | 0.30 | 0.21 | 0.28 | 0.08 | 0.03 | 0.05 | 0.04 | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | -0.04 | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.90 | 0.85 | 0.81 | 0.69 | 0.47 | 0.31 | 0.22 | 0.23 | 0.18 | 0.30 | 0.21 | 0.28 | 0.08 | 0.03 | 0.05 | 0.04 | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | -0.04 | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 1.17B | 1.17B | 1.18B | 1.18B | 1.18B | 1.18B | 1.15B | 1.14B | 1.15B | 1.07B | 796.95M | 486.82M | 973.47M | 687.25M | 667.33M | 667.43M | 634.73M | 568.31M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M |
| Weighted Avg Shares Out (Dil) | 1.17B | 1.17B | 1.18B | 1.18B | 1.18B | 1.18B | 1.15B | 1.14B | 1.16B | 1.07B | 796.95M | 486.82M | 973.47M | 687.25M | 667.33M | 667.43M | 634.73M | 568.31M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M | 634.73M |
No news found for: 000739.SZ
Source: https://incomestatements.info
Category: Stock Reports